The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
263 jobs Number of planned job creations
Announcement Date
2 October 2012
Employment effect (start)
2 October 2012
Foreseen end date
Description
Teva Pharmaceutical Works has opened its new site in Gödöllő, where it hired 263 employees. As announced, the new plant will manufacture sterile pharmaceutical products.
The Israel-based group present in Hungary since 1993, is currentrly employing more than 3,500 people.
Sources
2 October 2012: Origo
2 October 2012: Menedzser Fórum
2 October 2012: Index
Citation
Eurofound (2012), Teva Pharmaceutical Works, Business expansion in Hungary, factsheet number 74256, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/74256.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
